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Abstract
Background: In-hospital logistic management barriers (LMB) are considered to be important risk factors for delays
in TB diagnosis and treatment initiation (TB-dt), which perpetuates TB transmission and the development of TB
morbidity and mortality. We assessed the contribution of hospital auxiliary workers (HAWs) and 24-h TB laboratory
services using Xpert (24h-Xpert) on the delays in TB-dt and TB mortality at Beira Central Hospital, Mozambique.
Methods: A quasi-experimental design was used. Implementation strategy—HAWs and laboratory technicians were
selected and trained, accordingly. Interventions—having trained HAW and TB laboratory technicians as expediters
of TB LMB issues and assurer of 24h-Xpert, respectively. Implementation outcomes—time from hospital admission
to sputum examination results, time from hospital admission to treatment initiation, proportion of same-day TB
cases diagnosed, initiated TB treatment, and TB patient with unfavorable outcome after hospitalization (hospital TB
mortality). A nonparametric test was used to test the differences between groups and adjusted OR (95% CI) were
computed using multivariate logistic regression.
Results: We recruited 522 TB patients. Median (IQR) age was 34 (16) years, and 52% were from intervention site,
58% males, 60% new case of TB, 12% MDR-TB, 72% TB/HIV co-infected, and 43% on HIV treatment at admission. In
the intervention hospital, 93% of patients had same-day TB-dt in comparison with a median (IQR) time of 15 (2)
days in the control hospital. TB mortality in the intervention hospital was lower than that in the control hospital
(13% vs 49%). TB patients admitted to the intervention hospital were nine times more likely to obtain an early
laboratory diagnosis of TB, six times more likely to reduce delays in TB treatment initiation, and eight times less
likely to die, when compared to those who were admitted to the control hospital, adjusting for other factors.
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Conclusion: In-hospital delays in TB-dt and high TB mortality in Mozambique are common and probably due, in
part, to LMB amenable to poor-quality TB care. Task shifting of TB logistic management services to HAWs and lower
laboratory technicians, to ensure 24h-Xpert through “on-the-spot strategy,” may contribute to timely TB detection,
proper treatment, and reduction of TB mortality.
Keywords: Tuberculosis, Hospital auxiliary workers, 24-h TB laboratory using Xpert, Same-day TB diagnosis and
treatment, Hospital TB mortality
Contributions to the literature
 The use of layperson in hospital settings and routine
availability of molecular TB diagnostic tools are
known to be helpful in speeding up early TB
diagnosis and treatment.
 Our study found that having HAWs as expediters of
logistic and operational TB matters and 24-h avail-
ability of Xpert at admission point contributed to
same-day TB diagnosis and treatment in about 93%
of all suspected TB patients and reduced TB
mortality.
 These findings suggest that 24 h of TB services
using molecular TB diagnostic tools should reduce
in-hospital TB delays and mortality due to TB care
cascade gaps.
Background
Despite falling tuberculosis (TB) incidence rates globally
and in the WHO African Region, Mozambique shows an
increasing trend of TB incidence within the last 5 years,
and in 2017, it was ranked in the 11th place among the
20 countries with the highest burden of TB, with inci-
dence rate estimated at 551/100 000 inhabitants in the
general population [1].
Mozambique has a national policy on TB infection con-
trol (TBIC) in healthcare facilities, congregate settings,
and households [2]. However, barriers to operationaliza-
tion and adherence to TBIC measures within healthcare
facilities remain [3, 4], which is contributing to TB diag-
nostic and treatment delays, onward TB transmission, and
death [3, 5, 6].
In most of the health facility settings in Mozambique,
TB care cascade gaps are common. Suspected TB patients
are admitted directly to the general medical wards, fre-
quently without an adequate screening for TB at the ad-
mission point, where they wait to be tested. Unfortunately,
even after their hospital admission, many still experience
delays of weeks or months before getting thoroughly ex-
amined for TB diagnosis and treatment. In addition, hos-
pital TB mortality persists in Beira city, in part due to TB
diagnosis and treatment delays related to logistical and op-
erational barriers within a healthcare system or in-ward
environmental which hinder the impact of government
investments on TB infection control and prevention in the
last 5 years [7–9].
The lack of designated logistic TB staff and limited TB
services within the health facilities in Mozambique are
known to be important factors associated with the lack
of expedition of sputum collection and its examination
results, and accumulation (overload) of untested sputum
samples, respectively [5, 7, 8]. Because of these short-
comings, the median (IQR) time delay of Xpert and
smear microscopy sample testing response from sample
collection was about 10 (9) days in 2018 instead of the
normally expected 2 h [7] and 62 (83) days in 2013 [5],
respectively, due to health system delays, within the pub-
lic health facilities in Beira city.
Appointing a cough officer nurse to deal with and ex-
pedite all TB matters is an intervention that has proven
to be effective at decreasing delays in TB diagnosis and
treatment in other contexts [10–12].
However, nurses are overwhelmed in Mozambique, as
the country’s nurse to population ratio is about 2.9 per
10 000 inhabitants [13]. The use of trained laypersons in
hospital settings in Kenya was successfully observed to
be helpful on early TB case detection and treatment
[14]. On the other hand, having 24-h TB laboratory ser-
vices, ensuring routine and urgent TB diagnostic tools
(GeneXpert MTB/RIF assay, for instance) available every
day, including weekend and (inter) national holidays, is
an effective intervention, not only in reducing nosoco-
mial transmission of TB but also in speeding up early
TB diagnosis and treatment [7, 12, 15].
The use of hospital auxiliary workers (HAWs) by the
Mozambique Ministry of Health to support and expedite
all logistic TB matters within the medical wards of pub-
lic health facilities is on-going as a routine task of this
category of workers. However, published data on the
contribution of this approach to the reduction of TB
diagnosis and treatment delays and implementation of
infection prevention and control measures in healthcare
facilities is unavailable. On the other hand, despite clin-
ical laboratories of the public hospitals are open 24 h
per day, it is quite common that TB laboratories are
closed after 3:00 PM, on weekends, or on (inter) national
holidays [7]. In addition, little is being done around the
country in relation to the availability of 24-h TB
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laboratory services as one of the main strategies for TB
infection prevention and control [2, 16].
To address these logistic management barriers in rela-
tion to TB diagnosis and treatment delays, an implemen-
tation science study was conducted. The aim was to
assess whether the use of HAWs and the availability of
24-h TB laboratory services using Xpert should reduce
delays in TB diagnosis, treatment, and hospital TB mor-
tality. The study was carried out at Beira and Nampula




Quasi-experimental studies [17] were used to assess the
contribution of HAW and 24-h TB laboratory services
on TB diagnosis, treatment delays, and TB mortality at
HCB. Data were collected retrospectively from medical
records for the 6-month period (from September 2017
to February 2018) preceding implementation in both
arms (intervention and control sites) and compared to
the 6-month period (from September 2018 to February
2019) post-implementation.
Study settings
The study was conducted in Beira Central Hospital
(HCB) as an intervention site and Nampula Central Hos-
pital (HCN) as a non-equivalent control site, chosen for
convenience. Beira city (the capital of Sofala Province) is
located in the central region of Mozambique and is the
second largest city in Mozambique, after Maputo city,
the capital of Mozambique. In 2019, the city of Beira
had about 465 918 inhabitants of which 50% were male
[18].
HCB is a referral hospital for three provinces (Sofala,
Manica, and Tete) and partly for the northern region of
Inhambane Province. Most of the TB-suspected patients
from these provinces are referred to this TB laboratory
for diagnosis, as it is the only one in the region equipped
with high-skilled personal and TB laboratory technology,
including GeneXpert MTB/RIF, culture, drug sensitivity
test (DST), and line probe assay (LPA) for Mycobacter-
ium tuberculosis complex. The hospital has seven med-
ical wards with about 300 beds, including two wards and
40 beds for TB patients [19].
HCN is located in the northern region of the country,
and it is also a referral hospital for three provinces
(Nampula, Cabo-Delgado, and Niassa) and partly for the
northern districts of Zambézia Province. In the HCN, al-
most all services and equipment are the same as those
existing in the HCB. The HCN is the only facility in the
northern region performing MTB culture, LPA, and
DST; hence, most of the TB-suspected patients are re-
ferred to and diagnosed. The flow chart of suspected TB
patients is entirely the same as HCB. HCN has four
medical wards with a capacity of about 250 beds, includ-
ing two wards and 50 beds reserved for TB patients.
Every suspected TB patient from the admission room is
sent directly to medical wards together with other kinds
of patients (there is no isolation room) until the TB
diagnosis is made. Those with laboratory-confirmed TB
are transferred out to the TB treatment wards. Import-
antly, weekend sputum examination is not performed,
and inward delays in TB diagnosis and treatment are
common [20].
Population, sampling, sample size, and exclusion criteria
Using a quasi-experimental design, probability sampling is
not applicable as the intervention aims to measure a new
hospital-wide model for care which will be implemented
throughout the hospital [17]. Therefore, all suspected pul-
monary TB patients with hospital admission were eligible.
Having HAW as an expediter of logistic TB matters and
24-h TB laboratory services for all suspected pulmonary
TB patients during their hospitalization was considered as
the primary point, and early TB diagnosis, treatment, and
TB mortality as the endpoint. However, suspected TB pa-
tients with psychiatry disorders or with unconsciousness,
younger than 18 years old, patients with confirmed TB,
and in treatment or with extrapulmonary TB were ex-
cluded from the study.
Study implementation strategy, intervention, and
intervention logic pathway
Implementation strategy
Ten HAWs were chosen for convenience and received
5-day training on (a) biosafety and sputum collection,
(b) logistics matters for early TB diagnosis and treat-
ment, and (c) evidence-based TB patient education cur-
riculum and psychosocial support. Similarly, all TB
laboratory technicians participated in 3-day training on
biosafety and sputum examination using national proto-
cols for sputum smear microscopy and GeneXpert
MTB/RIF examination procedures [21, 22]. The train-
ings were conducted by local healthcare professionals in
collaboration with the research team.
The objective of the implementation strategy was to
ensure that HAWs have knowledge of and are imple-
menting the terms of reference of a hospital-based ex-
pediter of logistic TB matters (as described in Table 1),
and TB laboratory technicians are engaged to the early
TB diagnosis and implementation of hospital TB control
infection and prevention measures.
Intervention
The intervention was implemented within the 6-month
period (from September 2018 to February 2019). The
main interventions were having HAWs (within the
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medical wards and at admission point) and TB laboratory
technicians, as expediter of logistic management TB mat-
ters and ensuring 24-h TB laboratory services, including
weekends and (inter) national holy days, respectively.
The HAWs were not devoting to exclusively attending
to TB duties but also were coordinating/collaborating
with emergency room and medical ward teams, and
therefore, other workplaces were not being neglected.
Similarly, TB laboratory technicians were integrated into
24-h work shifts/schedules to overcome the limited
working hours of the TB laboratory.
Before implementing the intervention, meetings were
held with all managers, medical doctors, and nurses, in
collaboration with the hospital leadership aiming to in-
form and ask support for effective logistic management
of commodities and changes on working hours of the
hospital TB services and flow chart for sputum sampling
collection, examination, and delivery of positive results.
In addition, the hospital leadership recommended that
any HAW and/or TB laboratory technician who should
integrate into 24-h work shifts/schedules and has more
than 40 working hours per week should be paid stipends
according to the Mozambique Ministry of Health regula-
tions for extra working hours.
Intervention logic pathway
The intervention package was given to all eligible pa-
tients; however, data collection and documentation
were done only for those who signed the written in-
formed consent. The package was composed of (a)
sputum collection at admission point, (b) expedition
of TB diagnosis and treatment initiation, and (c) TB
patient education and psychosocial support during
the hospitalization. Details of each component are
given below.
Immediate collection of sputum sample In collabor-
ation with medical doctors, the HAW equipped with the
respiratory N95 masks were responsible to identify sus-
pected pulmonary TB patients with hospital admission
but still in the emergency room (admission point) or in
the medical wards and ensure that sputum request form
is correctly filled out and the sputum sample is immedi-
ately collected at any time—“on-the-spot strategy”—and
send to TB laboratory as soon as possible. If the result of
sputum examination through “on-the-spot strategy” was
negative, the second sputum sample should be collected
the next morning and send to the TB laboratory as soon
as it is collected.
For the biosafety purposes, patients were guided to step
off the emergency room or general medical wards to pro-
duce a sputum sample in the open air (previously identi-
fied) and away from other people to avoid possible
transmission of M. tuberculosis or other airborne patho-
gens. HAWs were instructed to help the patients to fasten
the lid (or to do it if the patient is unable) once the sputum
sample has been added. Then, the HAW could safely trans-
fer the sputum sample to the staff on the TB laboratory.
Expedition of TB diagnosis and treatment initiation
To overcome the limited TB laboratory services
provision, which seems to contribute to sputum sample
overload and, consequently, delays in TB diagnosis and
treatment initiation, work shift or scheduled work of TB
laboratory technicians were designed according to the
Ministry of Health (MoH) regulations.
Having 24 h of TB laboratory technicians, the sputum
sample collected by the HAW at the admission point or
general medical wards and sent to the TB laboratory was
examined as soon as the technician received it.
In collaboration with the laboratory technicians, the
HAWs were instructed to collect, in every 3 h at max-
imum, all sputum examination results, from the TB la-
boratory to the medical doctor’s office.
As soon as the diagnosis of pulmonary TB was made,
the HAWs were isolating the TB patients by taking them
to the TB wards, initiating TB treatment and ensure the
provision of the respiratory N95 masks to healthcare
workers, patients, and visitors.
TB patient education and psychosocial support An
evidence-based TB patient education curriculum was de-
signed, adopted from the Centers for Disease Control
and Prevention (CDC) TB patient education material
[23]. There were four main topics designed to explain
key points of local misunderstanding about (a) facts of
Table 1 Terms of reference of the hospital-based expediter of
logistic TB matters—Beira, Mozambique
In collaboration with medical doctors, to identify TB suspected patients
in the emergency room or in the medical wards daily (24 h per day)
and ensure that sputum request form is correctly filled out, sputum
sample is immediately collected at admission point and sent to TB
laboratory as soon as possible. If the result of sputum examination
through “on-the-spot strategy” is negative, another sputum sample must
be collected in the next morning and send to the TB laboratory as soon
as it is collected.
In collaboration with laboratory technicians, collect sputum smear
microscopy or Xpert MTB/RIF results from the TB laboratory, in every 3 h,
and give them immediately to medical doctors in order to ensure early
treatment initiation for those patients with positive MTB.
To ensure the provision of the N95 masks and prompt isolation of all
pulmonary TB patients as soon as the diagnosis is made, taking them
out from emergency room/general medical ward directly to the TB
ward.
In collaboration with medical ward nurses, to ensure personalize
psychosocial support and conclusion of evidence-based curriculum of
TB patient education (within 3 days) to all TB patients (including their
families and visitors whenever possible) about the misunderstanding of
the TB, its cause, modes of transmission and prevention, treatment and
related side effects, reasons for 6-month period (or more) of TB treat-
ment, and the consequences of giving TB treatment up.
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TB infection and disease; (b) modes of transmission and
protecting family and friends; (c) facts of TB treatment
and related side effects, including reasons for the 6-
month period (or more) and the consequences of giving
TB treatment up; and (d) connection between TB and
HIV and its effective control measures.
In collaboration with medical ward nurses, HAWs were
ensuring two kinds of TB education sessions: individual
and in groups. The individual sessions, also known as per-
sonalized psychosocial support, were given in the treat-
ment room, once per day; while the sessions in groups
were given twice per day, during lunch and dinner times.
The topics could be repeated as many times as neces-
sary to ensure further understanding of TB facts in rela-
tion to the local beliefs (like TB is a matter of witchcraft,
TB has no cure, everyone who has TB also has HIV,
using the same tableware with TB patients may have tu-
berculosis). In addition, the TB education sessions were
also directed to TB patient family members and friends
during their hospital visits, whenever possible.
Data collection, variables, and implementation outcome
Data were extracted from the laboratory and treatment
registration books, including demographic and clinical
data such as sex, age, HIV and treatment status, WHO
clinical stages of HIV, sputum smear microscopy result,
and GeneXpert sputum results, as well as (a) the date re-
corded for hospital admission, (b) the date recorded for
positive smear microscopy and/or GeneXpert assay, (c)
the date recorded for anti-TB treatment initiation, and
(d) the medical outcome of the TB patients admitted to
medical wards.
The main study implementation outcomes were (a) time
from hospital admission to sputum examination results,
(b) time from hospital admission to treatment initiation,
and (c) proportion of same-day TB cases diagnosed, initi-
ated TB treatment, and TB patient with unfavorable out-
come after hospitalization (hospital TB mortality).
Data analysis
Descriptive statistics (frequencies, percentages, medians
with interquartile range (IQR)) were used to summarize
patient characteristics. Time delays from admission to
TB diagnosis and treatment initiation and TB mortality
after hospital admission were assessed. Differences in
the proportions across the groups were compared using
the chi-square test of proportions. Mann-Whitney U
nonparametric test and logistic regression and its ad-
justed odds ratio (aOR) at 95% confidence interval were
used to assess the difference and the effect of interven-
tion, respectively, of the median time delays from hos-
pital admission to TB diagnosis, TB treatment initiation
and hospital TB mortality between the two groups
(intervention and control sites) in both, before and after
intervention periods, respectively. We consider a signifi-
cance level of 5% for all statistical analysis. Statistical
Package for Social Sciences (SPSS) version 20 for Win-
dows was used for data analysis.
Results
Clinic-epidemiological characteristics of the TB patients
A total of 522 TB patients were included in the analysis,
of which 52% are from the intervention site. The period
before the intervention, clinic-epidemiological data of
219 TB patients from both sites were retrieved and 103
(47%) from the intervention site. While in the interven-
tion phase, 303 TB patients were enrolled and followed
up, of which 167 (55%) were beneficiaries of the inter-
ventions and 136 (46%) were in the control site.
From the total, 302 (58%) were males and 220 (42%)
females, median (IQR) age was 34 (16) years and the
most frequent (34%) age category was 25–34. About 367
(72%) patients were TB/HIV co-infected, and only 162
(43%) were on HIV treatment at admission (Table 2). In
general, the clinic-epidemiological characteristics (sex,
age, and history of TB disease) were similar (P > 0.05) in
both sites, either before or after the intervention, except
for HIV and antiretroviral treatment status that had sta-
tistically differences (P < 0.05).
Fidelity to deliver the intervention and implementation
strategy
The delivery of the intervention through the expected
logic pathway was measured either by intervention deliv-
ery forms or by questionnaire applied to patients. About
97.9% and 81.6% of all patients with 1 week or more of
hospitalization confirmed to receive, at least, two times
and three times, respectively, all expected deliverables.
The extra hours’ stipend, the regular provision of N95
respiratory masks, supervision, and effective communi-
cation were the main motivational influences by the TB
laboratory technicians and HAWs.
The implementation strategy was delivered as planned
among almost all the main stakeholders (TB laboratory
technicians, medical doctors, nurses, and HAWs, as well as
visitors). The trainings on biosafety and Xpert examination
procedures, the regular provision of N95 respiratory masks,
and the engagement of the program managers and hospital
decision-makers seem to have contributed successfully to
the fidelity to deliver the implementation strategy. Supervi-
sion and effective communication played an important role
in the successful implementation of the intervention.
Time from hospital admission to laboratory TB diagnosis
The total median (IQR) time delays from hospital ad-
mission to TB diagnosis before the intervention in both
control [9 (3) days] and intervention [10 (2) days]
groups were statistically similar (P = 0.199). However,
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Table 2 Clinic-epidemiological characteristics of the TB patients admitted to Beira and Nampula Central Hospitals, Mozambique
Characteristics Before intervention After intervention
Control site, no. Intervention site, no. P value (chi-square) Control site, no. Intervention site, no. P value (chi-square)
Sex
Male 67 59 0.077 77 99 0.658
Female 49 44 59 68
Total 116 103 136 167
Age categories
15–24 years old 23 12 0.099 23 32 0.147
25–34 years old 39 44 43 51
35–44 years old 29 23 32 41
45–54 years old 13 16 17 27
> 55 years old 12 8 21 16
HIV status
Positive 72 84 0.010 72 139 0.010
Negative 44 19 64 28
Highly active antiretroviral treatment (HAART)
On HAART 11 37 0.001 41 73 0.001
Not on HAART 105 66 95 94
History of TB treatment and sensitivity to drugs
New case 77 66 0.106 78 91 0.106
Relapse 33 25 43 45
MDR TB 6 12 15 31
Fig. 1 Median time delay from hospital admission to laboratory TB diagnosis, Beira and Nampula Central Hospitals, Mozambique (produced
by authors)
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after the implementation of the intervention, there were
statistically significant differences (P = 0.001) in the me-
dian (IQR) time delays in TB diagnosis within the con-
trol group [10 (3) days] in comparison with the
intervention group [1 (1) day] (Fig. 1).
Time from hospital admission to TB treatment initiation
In the intervention site, in terms of delays from hos-
pital admission to TB treatment initiation, a statisti-
cally significant difference (P = 0.001), from a median
(IQR) time of 15 (3) days before the intervention to a
median (IQR) time of 1 (1) day after intervention,
was observed. In addition, the data indicated there
was no significant difference in the control group
(P = 0.191), between the medians (IQR) and time
delay of 14 (4) days and 15 (2) days observed before
and after the intervention period, respectively (Fig. 2).
Proportion of same-day TB patients diagnosed, initiated
TB treatment, and TB mortality
Every suspected TB patient admitted to medical wards
was sent to HAW for TB matter expedition (early diag-
nosis and treatment initiation) together with 24-h TB la-
boratory performance, TB education, and follow-up
during the hospitalization period.
The HAWs, working as logistic TB matter exped-
iter, had contributed for early sputum sample collec-
tion and same-day TB diagnosis of about 84% (141/
167) of all suspected TB patients at admission point,
through “on-the-spot strategy,” and about 93% (156/
167) of all TB patients have started TB treatment
initiation within 24 h, in comparison with 7% of
same-day TB diagnosis and 6% of treatment initiation
observed in the control hospital. In addition, immedi-
ate isolation of these 156 TB patients was ensured. In
terms of hospital TB mortality, the data show that
after the intervention period, there is a statistically
significant difference (P = 0.001), with 12.6% of TB
mortality in the intervention hospital against 49.3% in
the control hospital (Table 3).
Implementation outcomes and its correlates
In terms of the effect of intervention, the data analysis
showed that suspected TB patients admitted to the
intervention hospital were nine times more likely to ob-
tain an early laboratory diagnosis of TB (aOR = 9.21,
95% CI 7.52–12.11), when compared with those who
were admitted to the control hospital, adjusting for other
factors.
Similarly, it seems that the intervention has an impact of
six times (aOR = 6.03, 95% CI 4.71–8.93) more likely to
reduce delays in TB treatment initiation from hospital ad-
mission, when compared to those patients who were ad-
mitted to the control hospital, adjusting for other factors.
Unfortunately, TB patients admitted to the control
hospital have eight times (aOR = 8.31, 95% CI 5.93–
10.71) more likely to die when compared to patients in
the intervention hospital, adjusting for other factors.
This result suggests that the intervention has a possibil-
ity to avert the hospital TB mortality when compared to
pre-intervention results (aOR = 1.29, 95% CI 0.83–2.42),
adjusting for other factors (Table 4).
Fig. 2 Median time delay from hospital admission to TB treatment initiation, Beira and Nampula Central Hospitals, Mozambique (produced
by authors)
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Discussion
The study results demonstrate higher delays in TB diag-
nosis and treatment within the control hospital settings
in comparison with the results from intervention hos-
pital, particularly after the implementation of the inter-
vention. This is due to the frailties of the national TB
program to ensure adequate quality of TB services deliv-
ery, as suspected TB patients within hospital settings
often are neither identified nor thoroughly evaluated in
a timely manner. Even if TB diagnosis is confirmed, TB
patients are not initiated on treatment or psychosocially
supported to adhere and complete TB treatment for ef-
fective cure.
This finding is in agreement with several studies, in-
cluding from Mozambique [5, 7], Tanzania [24] South
Africa [25], and Pakistan [26]. Despite scaling-up of
rapid molecular TB test, evidences are supporting that
health system delays in TB diagnosis and treatment are
due, in part, to TB laboratory operational delays (limited
working hours of TB laboratories vs underutilization of
molecular diagnostic tools) [7, 24, 27] and TB care
cascade gaps, worsened by the lack of trained TB front-
line staff to ensure expedition of logistic TB matters and
linkage to and retention in TB treatment [5, 25–28].
Having trained HAW as expediter of logistic manage-
ment TB issues and availability of 24-h TB laboratory
services using Xpert contributed to same-day TB diag-
nosis and treatment. To our best knowledge, this is the
first time in Mozambique to document the collection of
sputum sample at admission point through “on-the-spot
strategy,” which is sent immediately to the TB labora-
tory, and availability of 24-h Xpert TB testing has con-
tributed efficiently to ensure that 93% of all suspected
pulmonary TB patients had their TB diagnosis and treat-
ment initiation within 1 day. Additionally, the research
team noticed that Xpert examination of a single spot
sputum sample “on-the-spot strategy” at admission point
has a greater yield (93%) and minimizes the workload of
TB laboratory technicians and TB delays, when com-
pared to the morning sputum sample collection strategy.
This finding is consistent with those documented by
Barrera et al. [29] and Shete et al. [30] in relation to
Table 3 Intervention and hospital outcomes in Beira and Nampula Central Hospitals, Mozambique
Outcome measures Before intervention Before intervention
Control site % Intervention site % P value Control site % Intervention site % P value
Sputum sample collection site
Admission point 7 6.0 9 8.7 0.395 12 8.8 141 84.4 0.001
Medical ward 109 94.0 94 91.3 124 91.2 26 15.6
TB diagnosis after hospital admission
Median time of 1 day 6 5.2 7 6.8 0.517 9 6.6 141 84.4 0.001
Median time of 10 days 110 94.8 96 93.2 127 93.4 26 15.6
TB treatment initiation after hospital admission
Median time of 1 day 6 5.2 7 6.8 0.901 8 5.9 156 93.4 0.001
Median time of 14 days 110 94.8 96 93.2 128 94.1 11 6.6
Health outcome among TB patients
Hospital discharge 62 53.4 47 45.6 0.093 69 50.7 146 87.4 0.001
Hospital deaths 54 46.6 56 54.4 67 49.3 21 12.6
Table 4 Implementation outcomes and its correlates in Beira and Nampula Central Hospitals, Mozambique
Outcome measures Before intervention P
value
After intervention P
valueAdjusted odds ratio (aOR) 95% CI (min-max) Adjusted odds ratio (aOR) 95% CI (min-max)
Sputum sample collection site [reference, control hospital]
Admission point 0.96 0.01–2.07 0.811 10.97 9.48–11.79 0.001
Lab TB diagnosis [reference, control hospital]
Median time of 1 day 0.83 0.05–1.90 0.628 9.21 7.52–12.11 0.001
TB treatment initiation [reference, control hospital]
Median time of 1 day 1.01 0.61–2.99 0.553 6.03 4.71–8.93 0.001
Health outcome [reference, intervention hospital]
Hospital deaths 1.29 0.83–2.42 0.779 8.31 5.93–10.71 0.001
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same-day TB diagnosis, treatment, and significant reduc-
tion of delays. These studies are supporting the import-
ance of expedition strategies for early TB diagnosis and
treatment initiation through designating and training
hospital TB staff at the frontline to ensure all logistic TB
matters and using Xpert to speed up time to diagnosis
and effective treatment.
Finding TB cases actively by rapid molecular test, sep-
arating safely and treating effectively (FAST) is a strategy
known to address some TB implementation gaps [15, 29,
31], and it is in-line with one of the five priorities rec-
ommended by the Lancet Commission on building a
TB-free world [28]. However, in resource-limited set-
tings, TB laboratories using Xpert TB testing should per-
form 24 h per day to avoid either underutilization of
available resources or overload of sputum sample to be
examined coming from peripheral health centers [7, 12],
as replacing all smear microscopy to Xpert at peripheral
level may still take time in Mozambique.
One of the key innovative driving results of the inter-
vention was the significant reduction of hospital TB mor-
tality when compared to the control hospital, before and
after the implementation phase. The TB mortality within
the control hospital was unacceptable considering that TB
is a bacterial infection, curable for which there are effect-
ive diagnostic tools and medicines. Despite this not being
just a problem for Mozambique, as about 56% of all TB
deaths amenable to healthcare are due to poor-quality TB
service delivery [32, 33], the country national TB program
is called to act accordingly toward TB elimination.
During the study, we noticed that the same-day diagno-
sis and early treatment initiation, together with the indi-
vidual and collective patient education and psychosocial
support, may have contributed for the reduction of hos-
pital TB mortality, as misunderstanding of TB treatment
issues, particularly for treatment adherence and side ef-
fects, was carefully addressed. This result is in line with
the evidence supporting that delays in TB diagnosis and
treatment initiation are associated with the development
of severe forms of TB disease [34, 35] and TB mortality [7,
35–37]; therefore, prompt detection and proper anti-TB
drug initiation are the key actions to avert morbimortality
due to TB disease. In addition, promotion of task shifting
and expansion of molecular diagnostic tools together with
patient-centered high-quality TB services delivery are
known as important tools to ensure effective TB infection
prevention and control toward TB elimination [28, 32, 33,
38–40].
We anticipate that this study has limitations: using a
quasi-experimental design, probability sampling is not
applicable. Therefore, despite the availability of a similar
unit and comparable data, selection threat remains as
two units or institutions are rarely identical. However, a
time-series non-equivalent control group design is the
most powerful among all quasi-experimental alternatives
design.
Conclusion
In-hospital TB care cascade gaps and its related delays
in TB diagnosis and treatment and high TB mortality in
Mozambique are due to logistic and operational barriers
amenable to poor-quality TB care. From our experience,
we noticed that training HAWs on high-quality and
patient-centered TB services delivery and assigning them
to specific activities, together with 24 h of TB laboratory
services using Xpert, may reduce cascade gaps and ul-
timately; ensure timely TB detection and proper treat-
ment; and reduce its related mortality. Therefore, it is
time to have in Mozambique a health facility-based TB
quality improvement team and promote the “on-the-spot
strategy” and 24-h availability of TB laboratory services
using molecular diagnostic tools, particularly at periph-
eral health facilities, if TB is to be eliminated.
Abbreviations
aOR: Adjusted odds ratio; CIOB: Centro de Investigação Operacional da Beira;
FCG: Calouste Gulbenkian Foundation; HAW: Hospital auxiliary worker;
HIV: Human immunodeficiency virus; IF: Inês Fronteira; IHMT: Instituto de
Higiene e Medicina Tropical; INS: Instituto Nacional de Saúde;
IQR: Interquartile range; LMB: Logistic management barriers; ML: Miguelhete
Lisboa; MROM: Maria do Rosário O. Martins; NTP: National TB Program (NTP);
PHM: Paul H. Mason; TB: Tuberculosis; TB-dt: TB diagnosis and treatment
initiation; TBIC: TB infection control; UNL: Universidade Nova de Lisboa;
WHO: World Health Organization
Acknowledgements
The authors acknowledge the Tutorial Commission of the doctoral program
of ML (Professors Sonia Dias and Miguel Viveiros); people who helped in the
collection and processing of the database, namely Marques Nhamonga and
Joaquim Lequechane (CIOB staff), Dércia de Jesus Rodrigues, Magaia
Muarivai, Adérito Gustavo, and Argentino David (my undergraduate students
from ISCTAC, Beira); people who helped in the translation and review of the
manuscript, namely Barbara Burmen (my AuthorAid advisor), the CIOB
directorate and all colleagues, the Beira city health directorate and its all
health centers, Beira and Nampula Central Hospitals, specially the TB
laboratory staff and nurses of medical and TB wards, and the Fundação
Calouste Gulbenkian for sponsoring the doctoral program of ML under
award ID number P-135647/SBG/2014.
Authors’ contributions
ML conceived and designed the study, contributed to the data collection
and analysis, and wrote the first manuscript. IF, PHM, and MROM reviewed
the methods and interviews, contributed data collection tools, and reviewed
and improved the first manuscript. All authors read, reviewed, and approved
the final manuscript.
Funding
This study was elaborated based on the work of Miguelhete Lisboa doctoral
program, a Fundação Calouste Gulbenkian scholarship holder, and used
grants obtained from The Special Programme for Research and Training in
Tropical Diseases (TDR) and co-sponsored by the United Nations Children’s
Fund (UNICEF), United Nations Development Programme (UNDP), World
Bank, and World Health Organization (WHO)—award ID number: B40151/
2014.
The FCG and WHO/TDR were not involved in the design of the study and
collection; analysis and interpretation of data; and writing the manuscript;
therefore, the authors are responsible for all information.
Lisboa et al. Human Resources for Health           (2020) 18:28 Page 9 of 11
Availability of data and materials
The data that support the findings of this study are available from
Mozambique Ministry of Health, but restrictions apply to the availability of
these data, which were used under license for the current study, and so are
not publicly available. Data are however available from the authors upon
reasonable request and with permission from the Mozambique Ministry of
Health.
Ethics approval and consent to participate
The study was reviewed and approved by the institutional bioethics
committee for health of the National Institute of Health of Mozambique (ID:





The authors declare that they have no competing interests.
Author details
1Centro de Investigação Operacional da Beira (CIOB), Instituto Nacional de
Saúde (INS), Rua Correia de Brito #1323 – Ponta-Gea, Beira, Mozambique.
2Global Health and Tropical Medicine, Instituto de Higiene e Medicina
Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira No.
100 |, 1349-008 Lisbon, Portugal. 3School of Social Sciences, Monash
University, Wellington Road, Clayton, Victoria 3800, Australia.
Received: 10 September 2019 Accepted: 7 February 2020
References
1. WHO| World Health Organization, editor. Global tuberculosis report 2018.
Geneva; 2018. [cited 2019 Apr 14]. Available from: http://www.who.int/tb/
publications/global_report/en/.
2. MISAU. Ministério da Saúde. Mozambique Policy and Plan on TB Infection
Control in Health-Care Facilities and Congregate Settings. Moçambique:
Ministério de Saúde; 2010. [cited 2019 Aug 6]. Available from: http://www.
who.int/hiv/pub/guidelines/mozambique.pdf.
3. Brouwer M, Coelho E, Cd M, Brondi L, Winterton L, van Leth F. Healthcare
workers’ challenges in the implementation of tuberculosis infection
prevention and control measures in Mozambique. PLoS ONE. 2014;9(12)
[cited 2019 Aug 6];Available from: http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4266607/.
4. Naidoo S, Seevnarain K, Nordstrom DL. Tuberculosis infection control in
primary health clinics in eThekwini, KwaZulu-Natal, South Africa. Int J Tuberc
Lung Dis. 2012;16(12):1600–4.
5. Saifodine A, Gudo PS, Sidat M, Black J. Patient and health system delay
among patients with pulmonary tuberculosis in Beira city, Mozambique.
BMC Public Health. 2013;13:559.
6. Brouwer M, Coelho E, das Dores Mosse C, van Leth F. Implementation of
tuberculosis infection prevention and control in Mozambican health care
facilities. Int J Tuberc Lung Dis. 2015;19(1):44–9.
7. Lisboa M, Fronteira I, Colove E, Nhamonga M, Maria do Rosário OM. Time
delay and associated mortality from negative smear to positive Xpert MTB/
RIF test among TB/HIV patients: a retrospective study. BMC Infect Dis. 2019;
19(18) [cited 2019 Apr 15]. Available from: https://bmcinfectdis.
biomedcentral.com/articles/10.1186/s12879-018-3656-x.
8. Orlando S, Triulzi I, Ciccacci F, Palla I, Palombi L, Marazzi MC, et al. Delayed
diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: a
cost-effectiveness analysis of screening protocols based on four symptom
screening, smear microscopy, urine LAM test and Xpert MTB/RIF. PLoS One.
2018;13(7):e0200523.
9. García-Basteiro AL, DiNardo A, Saavedra B, Silva DR, Palmero D, Gegia M,
et al. Point of care diagnostics for tuberculosis. Pulmonology. 2018 Apr;
24(2):73–85.
10. Shenoi SV, Brooks RP, Catterick K, Moll AP, Friedland GH. ‘Cough officer’
nurses in a general medical clinic successfully detect drug-susceptible and
-resistant tuberculosis. Public Health Action. 2013;3(1):46–50.
11. Lin C-H, Tsai C-H, Liu C-E, Huang M-L, Chang S-C, Wen J-H, et al. “Cough
officer screening” improves detection of pulmonary tuberculosis in hospital
in-patients. BMC Public Health. 2010;10:238.
12. Harries AD, Maher D, Nunn P. Practical and affordable measures for the
protection of health care workers from tuberculosis in low-income
countries. Bull World Health Organ. 1997;75(5):477–89.
13. INE| Instituto Nacional de Estatistica. Anuário Estatístico, editor. “Statistical
yearbook” 2016: INE; 2017. [cited 2019 May 14]. Available from: http://www.ine.
gov.mz/estatisticas/publicacoes/anuario/nacionais/anuario-estatistico-2016.
14. Burmen BK, Mogunde J, Malika T. The use of laypersons to support
tuberculosis screening at a Kenyan referral hospital. Int J Prev Med. 2018;9
[cited 2019 Apr 15]. Available from: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC5981661/.
15. van Kampen SC, Susanto NH, Simon S, Astiti SD, Chandra R, Burhan E, et al.
Effects of introducing Xpert MTB/RIF on diagnosis and treatment of drug-
resistant tuberculosis patients in Indonesia: a pre-post intervention study.
PLoS One. 2015;10(6):e0123536.
16. MISAU - Ministério da Saúde. Plano Estratégico do Sector da Saúde (PESS)
2014-2019. 2013. Available from: http://www.nationalplanningcycles.org/
sites/default/files/planning_cycle_repository/mozambique/pess_30_
setembro_2013_detailh_com_anexos_vf_celia.pdf.
17. Polit DF, Beck CT. Nursing research: generating and assessing evidence for
nursing practice. 9th ed. Philandelphia: Williams & Wilkins; 2012. p. 257.
18. INE| Instituto Nacional de Estatistica, editor. Annual projections of the
population, urban and rural districts of Sofala province 2007–2040. Maputo;
2007. [cited 2019 Apr 16] p. 89. Available from: http://www.ine.gov.mz/
estatisticas/estatisticas-demograficas-e-indicadores-sociais/populacao/
projeccoes-da-populacao/projeccoes-2007-2040-sofala.pdf/view.
19. Direcção Provincial de Saúde de Sofala (DPS-Sofala). Sofala anual
tuberculosis report. Beira: National Tuberculosis Control Programme -
Ministéio de Saúde, Moçambique; 2019. p. 29–31.
20. Direcção Provincial de Saúde de Nampula (DPS-Nampula). "Nampula
Provincial Health Directorate". Nampula Anual Tuberculosis Report.
Nampula, Mozambique: National Tuberculosis Control Programme -
Ministério de Saúde, Moçambique; 2019 p. 43–5.
21. MISAU - Ministério de Saúde de Moçambique. Baciloscopy manual of
tuberculosis. Maputo: Programa Nacional de Controlo da Tuberculose –
PNCT; 2012. [cited 2019 Apr 16]. 54 p. Available from: https://www.fhi360.
org/sites/default/files/media/documents/TB%20Basiloscopy%20Manual.pdf.
22. MISAU - Ministério da Saúde. Directrizes para a implementação do GENEXPERT®
MTB/RIF em Moçambique. Moçambique: Ministério de Saúde; 2014.
23. CDC - The Centers for Disease Control and Prevention. Patient education
materials series: pamphlets, brochures, booklets. Tuberculosis. 2018; [cited
2019 Apr 18]. Available from: https://www.cdc.gov/tb/publications/
culturalmaterials.htm.
24. Mpagama SG, Mbelele PM, Chongolo AM, Lekule IA, Lyimo JJ, Kibiki GS,
et al. Gridlock from diagnosis to treatment of multidrug-resistant
tuberculosis in Tanzania: low accessibility of molecular diagnostic services
and lack of healthcare worker empowerment in 28 districts of 5 high
burden TB regions with mixed methods evaluation. BMC Public Health.
2019;19(1) [cited 2019 Apr 21]. Available from: https://bmcpublichealth.
biomedcentral.com/articles/10.1186/s12889-019-6720-6.
25. Cox H, Dickson-Hall L, Ndjeka N, van’t Hoog A, Grant A, Cobelens F, et al.
Delays and loss to follow-up before treatment of drug-resistant tuberculosis
following implementation of Xpert MTB/RIF in South Africa: A retrospective
cohort study. PLoS Med. 2017;14(2) [cited 2019 Apr 21]. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319645/.
26. Ali SM, Naureen F, Noor A, Fatima I, Viney K, Ishaq M, et al. Loss-to-follow-
up and delay to treatment initiation in Pakistan’s national tuberculosis
control programme. BMC Public Health. 2018; [cited 2019 Apr 21];18.
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845151/.
27. Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD,
et al. Implementation of GenoType MTBDRplus reduces time to multidrug-
resistant tuberculosis therapy initiation in South Africa. Clin Infect Dis Off
Publ Infect Dis Soc Am. 2013;56(4):503–8.
28. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R,
et al. Building a tuberculosis-free world: the Lancet Commission on
tuberculosis. Lancet. 2019;393(10178):1331–84.
29. Barrera E, Livchits V, Nardell E. F-A-S-T: a refocused, intensified,
administrative tuberculosis transmission control strategy. Int J Tuberc Lung
Dis. 2015;19(4):381–4.
Lisboa et al. Human Resources for Health           (2020) 18:28 Page 10 of 11
30. Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, et al. Feasibility
of a streamlined tuberculosis diagnosis and treatment initiation strategy. Int
J Tuberc Lung Dis. 2017;21(7):746–52.
31. Le H, Nguyen N, Tran P, Hoa N, Hung N, Moran A, et al. Process measure of
FAST tuberculosis infection control demonstrates delay in likely effective
treatment. Int J Tuberc Lung Dis. 2019;23(2):140–6.
32. Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, et al.
High-quality health systems in the sustainable development goals era: time
for a revolution. Lancet Glob Health. 2018;6(11):e1196–252.
33. Pai M, Temesgen Z. Mind the gap: time to address implementation gaps in
tuberculosis diagnosis and treatment. J Clin Tuberc Mycobact Dis. 2017;6:
14–5.
34. Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, et al.
Treatment delay affects clinical severity of tuberculosis: a longitudinal
cohort study. BMJ Open. 2014;4(6) [cited 2019 Apr 4]. Available from: http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4067883/.
35. Jørstad MD, A mus J, Marijani M, Sviland L, Mustafa T. Diagnostic delay in
extrapulmonary tuberculosis and impact on patient morbidity: a study from
Zanzibar. PLoS One. 2018;13(9):e0203593.
36. Gaifer ZA. Risk factors for tuberculosis mortality in a tertiary care center in
Oman, 2006-2016. Int J Mycobacteriology. 2017;6(4):356–9.
37. Aljohaney AA. Mortality of patients hospitalized for active tuberculosis in
King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Saudi Med J. 2018;
39(3):267–72.
38. Vesga JF, Hallett TB, Reid MJA, Sachdeva KS, Rao R, Khaparde S, et al.
Assessing tuberculosis control priorities in high-burden settings: a
modelling approach. Lancet Glob Health. 2019 May;7(5):e585–95.
39. Dlodlo RA, Heldal E. Comprehensive care for all individuals with tuberculosis
is needed now. Lancet Glob Health. 2019;7(5):e536–7.
40. Pai M, Temesgen Z. Quality: the missing ingredient in TB care and control. J
Clin Tuberc Mycobact Dis. 2019;14:12–3.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Lisboa et al. Human Resources for Health           (2020) 18:28 Page 11 of 11
